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Tissue engineering strategies for repairing and regenerating articular cartilage face critical challenges to
recapitulate the dynamic and complex biochemical microenvironment of native tissues. One approach to
mimic the biochemical complexity of articular cartilage is through the use of recombinant bacterial
collagens as they provide a welledeﬁned biological ‘blank template’ that can be modiﬁed to incorporate
bioactive and biodegradable peptide sequences within a precisely deﬁned threeedimensional system.
We customized the backbone of a Streptococcal collagenelike 2 (Scl2) protein with heparinebinding,
integrinebinding, and hyaluronic acidebinding peptide sequences previously shown to modulate
chondrogenesis and then crosselinked the recombinant Scl2 protein with a combination of matrix
metalloproteinase 7 (MMP7)e and aggrecanase (ADAMTS4)ecleavable peptides at varying ratios to form
biodegradable hydrogels with degradation characteristics matching the temporal expression pattern of
these enzymes in human mesenchymal stem cells (hMSCs) during chondrogenesis. hMSCs encapsulated
within the hydrogels crosselinked with both degradable peptides exhibited enhanced chondrogenic
characteristics as demonstrated by gene expression and extracellular matrix deposition compared to the
hydrogels crosselinked with a single peptide. Additionally, these combined peptide hydrogels displayed
increased MMP7 and ADAMTS4 activities and yet increased compression moduli after 6 weeks, sug-
gesting a positive correlation between the degradation of the hydrogels and the accumulation of matrix
by hMSCs undergoing chondrogenesis. Our results suggest that including dual degradation motifs
designed to respond to enzymatic activity of hMSCs going through chondrogenic differentiation led to
improvements in chondrogenesis. Our hydrogel system demonstrates a bimodal enzymatically degrad-
able biological platform that can mimic native cellular processes in a temporal manner. As such, this
novel collagenemimetic protein, crosselinked via multiple enzymatically degradable peptides, provides
a highly adaptable and well deﬁned platform to recapitulate a high degree of biological complexity,
which could be applicable to numerous tissue engineering and regenerative medicine applications.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Developing bioengineered constructs for cartilage tissue engi-
neering that promote neocartilage regeneration by encapsulatedtevens).
e and Engineering & Bioen-
18015, USA.
r Ltd. This is an open access articlecells, while restoring both biomechanical and biochemical function
in damaged tissues, remains a signiﬁcant engineering challenge.
Human mesenchymal stem cells (hMSCs) provide an autologous
cell source that can be used to heal large osteoarthritic cartilage
lesions [1] and can be induced to undergo chondrogenesis when
subjected to speciﬁc biochemical and physical cues [2].
Threeedimensional (3D) environments have been shown to pro-
mote chondrogenesis of hMSCs [3e7]. Due to the importance of
culturing hMSCs in a 3D environment, a large number of studiesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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hydrogel scaffolds based on both synthetic and naturallyederived
materials including hyaluronic acid (HA) [3], poly(ethylene glycol)
(PEG) [4], agarose [5], alginate [6], and collagen [7], with each
presenting different advantages and disadvantages.
Hydrogels are particularly attractive cell carriers because their
elasticity and highly aqueous environments permit extracellular
matrix (ECM) evolution and nutrient transport, while physically
entrapping cells into the crosselinked network [8,9]. Additionally,
biodegradation is ideal to allow for cellular migration and pro-
gressive replacement of the template material by neotissue depo-
sition. Cellemediated degradation occurs in hydrogels made of
naturally derived materials such as collagen and ﬁbrin, and these
native molecules present moieties that can enhance cellular
adhesion and biorecognition [6]. However, it is difﬁcult to fabricate
reproducible, mechanically robust, or tunable scaffolds using nat-
ural materials [8]. The ability to tune the degradation of the
hydrogel with the deposition of ECM by harnessing cellemediated
processes has been shown to elicit advantages towards chondro-
genesis. Hydrogels can be programmed to degrade by cellemedi-
ated mechanisms, such as PEG hydrogels formed with matrix
metalloproteinase (MMP)edegradable crosselinks that were pre-
viously found to improve chondrogenesis of encapsulated hMSCs
compared to noneenzymatically degradable PEG hydrogels [10].
Hydrogels can also provide a welledeﬁned system that increases
their feasibility for clinical translation while recapitulating features
of natural systems such as cellemediated degradation and adhe-
sion to ECM molecules.
Recombinantly synthesized bacterial collagens, such as Strep-
tococcus collagenelike 2 (Scl2), have recently been explored for
numerous applications in tissue engineering and regenerative
medicine [11e14]. Scl2 proteins have been investigated largely due
to their modularity and ability to be manipulated via chemical
functionalization of amino acid residues or siteedirected muta-
genesis of selected peptide sequences to their backbone enabling
the tuning of speciﬁc cellular processes [11,14,15]. Scl2 proteins
contain the characteristic (GlyeXaaeYaa)n repeating sequence that
selfeassembles into a triple helical conformation much like
mammalian collagens [12,13,16]. In contrast to mammalian colla-
gens, however, bioactive epitopes that interact with cells are not
found on Scl2 proteins and thus, Scl2 proteins offer a welledeﬁned
biological ‘blank template’ onto which it is possible to selectively
and systematically integrate speciﬁc bioactive motifs [11,14,15].
Another advantageous feature of Scl2 proteins is their non-
eimmunogenicity and nonecytotoxicity as shown in a previous
study as well as the ability to produce these proteins at high yields
[12,13,15]. In addition, no postetranslational modiﬁcation of Scl2
proteins is required, resulting inminimal batchetoebatch variation
in performance, quality, and purity. Taken together, recombinantly
synthesizing collagenemimetic proteins may also reduce the
overall production costs compared to naturally occurring
mammalian collagens. Scl2 proteins have previously been used to
generate Scl2ebased hydrogels functionalized with glycosamino-
glycan (GAG)ebinding peptides and MMP7ecleavable peptide
crosselinks to promote the chondrogenic differentiation of
encapsulated hMSCs [11]. Additionally, Scl2 proteins containing
integrinebinding sequences have been combined with PEG to form
hydrogels that effectively bind smooth muscle and endothelial cells
for engineering vascular grafts [14].
The purpose of the current study was to build on the highly
promising previous ﬁndings on Scl2ebased hydrogels [11], which
showed that recombinant Scl2 proteins containing HAebinding
motifs enhanced chondrogenesis of encapsulated hMSCs to a
greater extent than either RGDS peptides or chondroitin sulfa-
teebinding motifs. Here, the backbone of Scl2 proteins wasmodiﬁed with HAebinding, heparin (H)ebinding, and integrin (I)e
binding sequences via siteedirected mutagenesis to enhance bio-
logical recognition and adhesion of encapsulated hMSCs. The I-
binding peptide sequence was included in the Scl2 protein con-
structs to aid initial cell adhesion to the scaffolds and maintain
viability. The welleknown RGD motif was not used in the present
study since it has been shown to lead to hMSC hypertrophy in
longeterm culture [4]. As such, the I-binding peptide used in the
present study was an alternative that does not include the RGD
sequence. The inclusion of the HAebinding motif was veriﬁed in
our previous work [11], and the reason for including all three of
these biological motifs was to provide celleadhesion and local
presentation of biomolecules in order to create a hydrogel envi-
ronment that mimics some of the characteristics of the highly
complex cartilage tissue environment. It was hypothesized that
chondrogenesis and cartilaginous matrix production would be
further improved by implementing a combination of degradable
peptides, where one peptide is targeted to an enzyme expressed by
hMSCs undergoing chondrogenesis and the other susceptible to
enzymes produced by the newly differentiated chondrocytes in
order to trigger ongoing scaffold degradation. Thus, an
MMP7ecleavable crosselinker to target enzymes produced during
the early stages of chondrogenesis was combined with a peptide
crosselinker that degraded speciﬁcally through the action of
mature chondrocytes. Two aggrecanases (A Disintegrin And Met-
alloproteinase with ThromboSpondin motif (ADAMTS); ADAMTS4
and 5) were selected due to their increased activity relative to
MMPs in mature cartilage tissue in vivo [17,18] and inactivity during
chondrogenesis before cells have committed to the chondrocyte
lineage [19]. These two aggrecanases speciﬁcally cleave aggrecan
(ACAN) at the TEGEeARG site in the interglobular domain [20], and
a previous study identiﬁed the ability of ADAMTS4 secreted by
chondrocytes to cleave a novel peptide crosselinker containing
that speciﬁc sequence. In that study, chondrocytes were encapsu-
lated in photopolymerized 8earm PEG hydrogels crosselinked
with the ADAMTS4ecleavable peptide, and the chondrocyte
phenotype (indicated by increased collagen type II deposition and
decreased collagen type I and X) was improved with the novel
ADAMTS4ecleavable crosselinker compared to nonedegradable
hydrogels [21]. Based on these observations, it was hypothesized
that the ADAMTS4ecleavable crosselinker would improve chon-
drogenesis and cartilaginous matrix deposition by the encapsu-
lated hMSCs. In this work, bioactive Scl2 proteins were
crosselinked with peptides speciﬁc to MMP7, ADAMTS4, or various
ratios of the two degradable crosselinkers, and the gene expression
and matrix production of encapsulated hMSCs were observed
throughout a 6 week culture period.
2. Materials and methods
2.1. Materials
Rink amide resin, Fmoceprotected amino acids, N, N dimethyl
formamide (DMF), dichloromethane (DCM), 20% (v/v) piperidine in
DMF,
OebenzotriazoleeN,N,N0,N0etetramethyluroniumehexaﬂuoroep-
hosphate (HBTU), and diisopropylethylamine (DIEA) were pur-
chased from AGTC Bioproducts (UK). MMP7 and ADAMTS4
ﬂuorogenic substrates were purchased from Merck Millipore (UK).
All primary and secondary antibodies used for immunohisto-
chemistry were purchased from Abcam (UK). All other chemicals
were purchased from SigmaeAldrich (UK). All chemicals were used
as provided by the manufacturers. Recombinant Scl2 proteins were
expressed in Escherichia coli BL21eDE3 and puriﬁed as described in
Section 2.3.
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The MMP7 (PLELRA)e, scrambled MMP7 (ScrMMP7; PALLRE)e,
and ACAN (RDTEGEARGSVIDR)ecleavable peptides were synthe-
sized manually on a 2 mmol scale using standard Fmoc solid phase
peptide synthesis techniques as previously described [22]. For each
coupling, the Fmoc protecting group was removed with 20% (v/v)
piperidine in DMF followed by washing with DCM and DMF. Amino
acids were activated by adding 4 molar equivalent of each Fmoc
protected amino acid to 3.95 molar equivalent of HBTU and dis-
solved in DMF. Sixmolar equivalent of DIEAwas added to the amino
acid solution and the coupling solution added to the resin. The
coupling reaction was allowed to proceed for two to three hours
before the resinwas washed in DCM and DMF. Ninhydrin tests were
performed after each Fmoc deprotection and coupling step to
monitor the presence of free amines.
FmoceLys(Mtt)eOH was also coupled to the peptides at the N
and C termini using methods described above. The ninhydrin test
for free amines was conducted at room temperature for 30 min
since the Mtt protecting group is heatelabile. The Mtt protecting
group was removed from the amine on the lysine side chain with
5% (v/v) TFA in DCM for 2 min on the shaker. The solution turns
bright yellow as theMtt is removed, and this was repeated at least 5
times or until the solution was clear. The beads were washed
thoroughly with DCM and DMF before running the ninhydrin test
at room temperature for 30 min. To attach acrylate groups to the
peptide, acryloyl chloride was activated by adding 10 molar
equivalents of acryloyl chloride and 10molar equivalents of DIEA in
DCM. The coupling was veriﬁed with the ninhydrin test at room
temperature for 30 min.
Once the synthesis was completed, the peptides were cleaved in
95% (v/v) triﬂuoroacetic acid (TFA), 2.5% (v/v) triisopropyl silane
(TIS), and 2.5% (v/v) H2O for four hours. TFA was removed using
rotary evaporation, and the peptide residues were precipitated and
washed with cold diethyl ether by centrifugation. The peptide
precipitates were then allowed to dry under vacuum to remove
residual ether. The peptides were puriﬁed (Fig. S1) using reverse
phase preparative high performance liquid chromatography (HPLC;
Shimadzu) in an acetonitrile/water gradient under acidic condi-
tions on a Phenomenex C18 Gemini NX column (5 mm pore size,
110 Å particle size, 150  21.2 mm). Following puriﬁcation, the
peptides were lyophilized on a freeze dryer (Labconco) for storage
at 4 C prior to use. The puriﬁed peptide masses were veriﬁed by
matrix assisted laser desorption spectroscopy (MALDI; Waters).
2.3. Streptoccocal collagenelike 2 protein synthesis and
puriﬁcation
The gene constructs used were based on the DNA sequence for
the fragment of the Scl2.28 allele (Q8RLX7) of Streptococcus pyo-
genes encoding the combined globular and collagenelike portions
of the Scl2.28 protein, but lacking the C terminal attachment
domain as previously described [12,13,15,23]. Constructs included
an additional enzyme cleavage and spacer sequence LVPRGSP be-
tween the N terminal globular domain (V) and the following
(GlyeXaaeYaa)n collagenelike (CL) domain sequences. The new
construct for the present study, HIHA-Scl2, contained a HAebind-
ing (RYPISRPRKR) sequence between two CL domains (Fig. 1). In
addition, each of the two CL domains included Hebinding
(GRPGKRGKQGQK) and Iebinding (GERGFPGERGVE) sequences
integrated within the triple helical structure, as previously
described [15]. The C terminal of this initial construct had an
additional C terminal GGPCPPC sequence. This DNA sequence was
synthesized commercially with codon optimization for expression
in E. Coli (GeneArt® Gene Synthesis, Germany). Subsequently, inorder to further stabilize the triple helix and allow for subsequent
functionalization via thioleacrylate chemistry, an additional
GGPCPPC sequence was added at the N terminal between the
spacer sequence and the CL domain, using the QuikChange
siteedirected mutagenesis kit (Stratagene) according to the man-
ufacturers' instructions and synthesized primers (Integrated DNA
Technologies). The sequences of the initial and ﬁnal constructs
were conﬁrmed by sequencing prior to transformation and protein
expression.
The ﬁnal DNA sequences were subecloned into the pColdI
(Takara Bio, Japan) vector systems for expression in E. coli (Fig. S2A).
The constructs did not include an N terminal His6etag, which was
provided by the pColdI vector [12,13,15,23]. For protein production,
a selected positive clone was transformed and then expanded in
ﬂask culture. The pColdI constructs were expressed in the E. coli
BL21eDE3 strain. Cells were grown in 2 yeast extractetryptone
(YT) media with ampicillin (100 mg/mL) at 37 C, with shaking at
200 rpm until the A600 absorbance reading reached an optical
density in the range 3e6 A.U. Cells were then cooled to 25 C and
1 mM isopropyl beDethiogalactopyranoside was added to induce
protein expression. After 10 h incubation, cells were further cooled
to 15 C for 14 h, after which the cells were harvested by centri-
fugation (12,000 g, 60 min) at 4 C. For protein extraction, each 1 g
of cell paste was reesuspended in 20 mL of 20 mM sodium phos-
phate buffer at pH 8.0 and the cells ruptured by sonication on ice
using a Misonix S4000 instrument with a Enhance Booster #1
probe [12,13,15,23]. Clariﬁed lysate (12,000 g for 30 min, 4 C) was
adjusted to pH 2.2 and held at 4 C for 16 h. Any precipitate that had
formed was removed (12,000 g for 30 min, 4 C) and the super-
natant, containing the expressed collagens, was treated by pepsin
(0.01 mg/mL) for 16 h at 4 C [23]. Collagens were concentrated and
buffer exchanged into 20 mM sodium phosphate buffer, pH 8.0
using a 10 kDa crosseﬂow ﬁltration membrane (Pall Life Sciences).
Purity was veriﬁed by 12% sodium dodecyl sulfateepolyacrylamide
gel electrophoresis (SDSePAGE) (Fig. S2B) and MALDI [12,13,15].
2.4. Characterization of functionalized Scl2 proteins
HIHA-Scl2 was characterized using Fourier transform infrared
(FTIR) spectroscopy to evaluate the conjugation chemistry. FTIR
analysis with a Perkin Elmer Spectrum One spectrometer was used
to evaluate the conjugation of the crosselinking peptides to Scl2
protein as previously described [14]. FTIR spectra were takenwith a
scanning wavenumber range from 4000 to 650 cm1.
2.5. Preparation of Scl2 hydrogels
To generate hydrogels, HIHA-Scl2 protein was reesuspended at
100 mg/mL in chondrogenic medium (medium deﬁned in Section
2.8) at room temperature. The MMP7ecleavable, nonecleavable
ScrMMP7, or ACANecleavable peptides were dissolved in 4 mM
triethanolamine (TEA) in chondrogenic medium and equimolar
equivalents of these peptides were reacted to modify 100% of the
thiols on the HIHA-Scl2 protein. The MMP7e and ACANecleavable
peptides were mixed in a 75:25, 50:50, and 25:75 M ratio. The
resulting solutions were sterileeﬁltered and pipetted to generate
homogeneous formation of ScrMMP7-HIHA-Scl2, MMP7-HIHA-
Scl2, MMP7:ACAN(75:25)-HIHA-Scl2, MMP7:ACAN(50:50)-HIHA-
Scl2, MMP7:ACAN(25:75)-HIHA-Scl2, and ACAN-HIHA-Scl2
hydrogels.
2.6. Hydrogel characterization
2.6.1. Morphological characterization
Hydrogels were imaged by multiephoton second harmonic
Fig. 1. Schematic diagrams of the peptideefunctionalized Scl2 protein and hydrogel. (A) Schematic diagram of the Scl2 protein containing Hebinding, Iebinding, and HAebinding
peptide sequences. The ‘CPPC’ domains represent the amino acid sequences inserted at the N and C termini to aid stability of each construct. (B) Generalized structure of the
peptideefunctionalized Scl2 protein and hydrogel. For clarity, the homotrimer chains are represented as different colors, and the triple helical motif has been opened out to show
the three chains. The locations of the Hebinding and Iebinding sites are not proportional to their locations in the construct. The 2earm acrylateefunctionalized MMP7 and ACAN
degradable peptides were conjugated to the Scl2 protein via thioleacrylate reactions to generate hydrogels. (C) Schematic diagrams of different Scl2 protein hydrogel samples.
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P.A. Parmar et al. / Biomaterials 99 (2016) 56e7160generation (MPeSHG) inwet state in PBS using a Leica SP5 inverted
microscope equipped with a MaiTai HP DeepSee multiephoton
laser (Spectraphysics) on a 25 NA objective. Second harmonic
signal was generated at 900 nm and detected on a photomultiplier
tube (PMT) (435e465 nm).
2.6.2. Mechanical characterization
Mechanical properties of the hydrogels were studied using
oscillatory shear rheology. Oscillatory parallel plate rheological
measurements were performed using an Advanced Rheometer
AR2000ex with AR Instrument Software (TA instruments) ﬁtted
with a Peltier temperature control system. Samples were tested at
37 C using an 8 mm diameter parallel steel plate. All samples were
individually prepared immediately prior to testing. Two sequential
sweeps were applied; (1) time sweep for 2 h at 0.1% strain and
6.28 rad/s angular frequency and (2) strain sweep from 0.01 to 100%
at 6.28 rad/s angular frequency. For all samples, a compression load
of 0.5 N was exerted during testing. Hydrogels were also studied
using dynamic mechanical analysis (DMA) in unconﬁned
compression mode. For all tests, samples were incubated in PBS for
24 h prior to testing to ensure samples were in an equilibrium state
and dimensions were measured in wet state using digital calipers.
Hydrogels were mechanically tested in compression using a Bose
Electroforce testing machine equipped with a 22.5 N load cell.
Samples were incubated in PBS, preeloaded to 0.05 N, compressed
to 10% strain at a crossehead speed of 0.5% strain/min, and then
followed by a frequency sweep from 0.1 Hz to 10 Hz. The
compressive modulus was calculated from the linear portion of the
stressestrain curve.
2.6.3. GAG binding
The effectiveness of the Hebinding and HAebinding peptide
sequences incorporated in the Scl2 backbone at binding and
retaining speciﬁc GAGs was evaluated using ﬂuorescein isothiocy-
anate (FITC)elabeled H and HA (Creative PEGWorks, UK). Scl2
proteins were coated onto 96ewell plates, incubated at 37 C for
24 h, washed three times in PBS, incubated in 1% (w/v) bovine
serum albumin (BSA) in PBS for 5 h, washed three times in PBS,
incubated in 0.5 mg/mL FITCelabeled H or HA for 24 h, washed
three times in PBS to remove unbound ﬂuorescent GAGs, and stored
in PBS at 37 C betweenmeasurements. To study the release of H or
HA from the hydrogels, they were processed exactly as proteine-
coated wells. After 1, 3, and 7 days, PBS was removed and ﬂuores-
cence intensities of the supernatants were measured to evaluate
GAG binding and retention. Samples were excited at 552 nm or
485 nm, and the ﬂuorescence emission intensity was measured at
575 nm or 525 nm for FITCelabeled H or HA, respectively. Samples
were incubated in fresh PBS at 37 C between readings. The ﬂuo-
rescence was measured in arbitrary units and relative binding of H
or HAwas normalized to the highest level of ﬂuorescent intensity at
each time point.
2.6.4. Swelling behavior
The swelling behavior of hydrogels was measured by recording
their dry weight (Wd) followed by swelling in 0.5 mg/mL H or HA in
PBS for 24 h at 37 C. The hydrogels were then removed from so-
lution at 2, 4, 6, 24, and 48 h post incubation, washed three times in
PBS, and their wet weight (Ws) was recorded. The swelling ratio of
the hydrogels was calculated using Equation (1) and normalized to
their swelling ratio in PBS without exogenous GAGs in the solution.
Swelling ratioð%Þ ¼
ðWsWdÞ
Wd

 100 (1)2.7. hMSC culture
Bone marrowederived hMSCs were purchased from PromoCell
GmbH (Germany). The multilineage differentiation capacity of
hMSCs was veriﬁed by PromoCell GmbH prior to purchase. hMSCs
were seeded at 4000 cells per cm2 in T225 ﬂasks and cultured in
mesenchymal stem cell growth medium (MSCGM) (PromoCell
GmbH, Germany). hMSCs were incubated at 37 C in a 5% CO2 at-
mosphere and the mediumwas changed every three days. The cells
were harvested at 80% conﬂuency with 0.025% (w/v) trypsineEDTA
in PBS, centrifuged, and subecultured in MSCGM. Passage 6 hMSCs
were used for all cell response experiments.
2.8. Cell seeding and culture
hMSCs were homogeneously dispersed at 8 106 cells per mL in
preemade 100 mg/mL HIHA-Scl2 solution containing chondro-
genic medium (higheglucose (4.5 g/L) Dulbecco's Modiﬁed Eagle
Medium (DMEM; Invitrogen, UK) supplemented with 0.1 mM
dexamethasone, 1% (v/v) penicillin streptomycin, 50 mg/mL
Leproline, 50 mg/mL ascorbatee2ephosphate, 1 insuline-
transferrineselenium (ITS) Premix (BD Biosciences, UK), and 10 ng/
mL TGFeb3 (Lonza, UK)). The MMP7, ScrMMP7, or ACAN peptides
were prepared in 4 mM TEA in chondrogenic medium and mixed
with the protein/cell solution. Aliquots (50 mL) of the resulting
mixture were pipetted in a nonetissue culture treated 48ewell
plate and allowed to gel for 30 min at 37 C in a 5% CO2 atmosphere
before slowly topping up the wells with 1 mL of chondrogenic
medium. Hydrogels were incubated at 37 C in a 5% CO2 atmo-
sphere for six weeks with the medium changed every three days.
Additionally, hMSCs were used in a pellet culture system. hMSCs
were homogeneously dispersed at 2.5  105 cells per mL in 1 mL
chondrogenic medium and centrifuged (400 g, 10 min) at 37 C in a
15 mL polypropylene conical tube. Pelleted cells were cultured for
two weeks at 37 C in a 5% CO2 atmosphere with loosened caps to
allow gas exchange and with the medium changed every three
days.
2.9. Weight change and enzymatic activity assays
The dry weight of each hydrogel was measured over time in
absence of cells to evaluate their degradation in vitro. Hydrogels
were prepared as previously described and incubated in chondro-
genic medium for 24 h at 37 C in a 5% CO2 atmosphere. The
hydrogels were then incubated in chondrogenic medium with
exogenous enzymes (30 ng/mL) at 37 C in a 5% CO2 atmosphere for
one week with medium changed and dry weight measurements
after lyophilization taken daily. Percentage weight change was
normalized to day 0. Degradation by recombinant human MMP1,
MMP2, MMP7, MMP13, and ADAMTS4 (AnaSpec, USA) was tested
against a negative control (chondrogenic medium alone) and a
positive control (0.2 mg/mL trypsin).
Celleseeded hydrogels were incubated in chondrogenic medium
at 37 C in a 5% CO2 atmosphere for six weeks, and dry weight
measurements after lyophilization were taken after 0, 1, 3, 7, 14, 21,
28, and 42 days of culture. Percentage weight change corresponding
to the cumulative effect of cell proliferation, cartilageelike matrix
deposition, and hydrogel degradation was normalized to day 0.
At each time point, 1 mL of medium was also removed, ster-
ileeﬁltered, and analyzed for MMP7 and ADAMTS4 activities.
MMP7 and ADAMTS4 activities were determined using ﬂuorogenic
MMP7 and ADAMTS4 substrate assays and compared to a negative
control (chondrogenic medium) and a positive control (recombi-
nant humanMMP7 and ADAMTS4) according to themanufacturers'
instructions.
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hMSCeseeded hydrogels were cultured for 0, 1, 3, 7, 14, 21, 28,
and 42 days. After the culture period, the hydrogels were washed
three times in PBS and analyzed for cell viability and adhesion. Cell
viability was qualitatively assessed with a LIVE/DEAD® Viability/
Cytotoxicity Kit (Molecular Probes, USA) according to the manu-
facturers' instructions. Fluorescence confocal microscopy (Leica SP5
invertedmicroscope, Leica Microsystems) was used to visualize live
(calcein; green) and dead (ethidium homodimere1; red) cells. The
metabolic activity of cells in the hydrogels was quantiﬁed by the
AlamarBlue® assay (Serotec, USA). This assay is based on the ﬂuo-
rescent signal output produced by metabolically active cells. Mea-
surements were made at 570 nm and 600 nm. Cellefree hydrogels
and empty wells were used as controls. All datawere normalized to
DNA content present (Section 2.11.) at each time point.
The effectiveness of the integrinebinding peptide sequence
incorporated into the Scl2 backbone at binding hMSCs was evalu-
ated using Scl2 proteins with (I-Scl2) and without (blank Scl2) the
integrinebinding motif. Scl2 proteins were coated onto 96ewell
plates, incubated at 4 C for 24 h, washed three times in PBS,
incubated in 2% (w/v) BSA in PBS for 2 h, washed three times in PBS,
and seeded with 2.5  105 cells/cm2 in serumefree medium. The
cells were incubated at 37 C in a 5% CO2 atmosphere for 90min and
washed three times in PBS. 100 mL of MTS solution (2 mL
3e(4,5edimethylthiazole2eyl)e5(3ecarboxymethoxphenyl)e
2e(4esulfophenyl)e2Hetetrazolium salt, 0.1 mL phenazine
methosulfate, and 10 mL serumefree medium) (Abcam, UK) was
added per well and samples were incubated at 37 C in a 5% CO2
atmosphere for 90 min. Absorbance of the samples was read at
490 nm and normalized to binding of cells to rat tail collagen type I.
2.11. DNA, sGAG, and hydroxyproline quantiﬁcation
hMSCeseeded hydrogelswere cultured for 0,1, 3, 7,14, 21, 28, and
42 days. After the culture period, the constructs were washed three
times in PBS and digested individually in papain digest solution (2.5
units papain/mL, 5 mM cysteine HCl, 5 mM EDTA, pH 7.4, in PBS) at
60 C for 24 h. Papain digests were stored at 20 C until further
analysis. Digested samples were assayed for DNA content using the
QuanteiT™ PicoGreen® Kit (Invitrogen, UK) according to the man-
ufacturers' instructions. Measurements were made at 535 nm. The
standard curve was generated with dsDNA (Invitrogen, UK).
Sulfated GAG (sGAG) content was quantiﬁed using the Blyscan
Kit (Biocolor, UK) according to the manufacturers' instructions.
Measurements were made at 656 nm. The standard curve was
generated with bovine trachea chondroitin sulfate A.
Total new, mammalian cellederived collagen content was esti-
mated by measuring the hydroxyproline content. Unlike mamma-
lian collagens, bacterial collagens lack hydroxyproline, which
enabled us to distinguish between the collagen in the hydrogel and
new collagen deposition by the hMSCs. Papainedigested samples
were hydrolyzed in 6 N HCl at 110 C for 18 h. The hydroxyproline
content of the hydrolysate was determined using the
chloramineeT/Ehrlich's reagent assay and the color change quan-
tiﬁed spectrophotometrically at 560 nm [24,25]. The standard
curve was generated with Lehydroxyproline and a conversion
factor of 10 was used to convert from hydroxyproline to total
collagen content.
2.12. Histology and immunohistochemistry
After 0 and 42 days of culture, hMSCeseeded hydrogels were
washed three times in PBS, ﬁxed with 4% (v/v) paraformaldehyde(Electron Microscopy Sciences, USA) for 30 min at 4 C, washed
three times in PBS, permeabilized with 0.4% (v/v) Triton Xe100 for
30 min, and washed again. Hydrogels were ﬂash frozen in OCT
(TissueeTek, Fisher Scientiﬁc, UK) and cryosectioned at a thickness
of 10 mm. Sections were transferred to treated slides (Superfrost
Plus, Thermo Scientiﬁc, UK) and allowed to adhere for 24 h at 4 C.
Slides were stained for deposited sGAG with Alcian Blue (AB; pH
2.5) and for cell nuclei and matrix with Haematoxylin and Eosin
(H&E).
Immunohistochemical staining (IHC) was performed for
collagen type I, collagen type II, collagen type X, SOX9, Runx2, and
PPAR-gwith rabbit IgG secondary antibody only and PBS negative
controls. Samples were preetreated with hydrogen peroxide, an
avidin and biotin blocking kit (Vector Labs, UK), and blocked with
5% (v/v) goat serum. Primary antibodies were incubated overnight
at 1/200 in 5% (v/v) goat serum, followed by goat antierabbit
secondary antibody labeled with HRP at 1:100 for 1 h, stained
with a 3,30ediaminobenzidine (DAB) kit (Vector Labs, UK) for
10 min, and counterestained with Haematoxylin. All stained
sections were dehydrated, mounted with Histomount (Fisher
Scientiﬁc, UK), and viewed on an Olympus BX51 microscope
equipped with an Olympus DP70 camera. Sections stained with
the SOX9 antibody were further examined to determine the
extent of hMSC chondrogenesis by obtaining the number of nuclei
stained positive for SOX9 at week 2 and normalizing to the total
number of nuclei.
2.13. Gene expression analysis
hMSCeseeded hydrogelswere cultured for 0,1, 3, 7,14, 21, 28, and
42 days. After the culture period, the constructs were washed three
times in PBS. Total RNA was isolated using a tissue ruptor (Qiagen,
USA) to homogenize samples with RLT buffer after which QIAshred-
der columns (Qiagen, USA) and the RNeasy Mini Kit (Qiagen, USA)
were used to extract the RNA according to the manufacturers' in-
structions. QuantiTect® Reverse Transcription Kit (Qiagen, USA) and
QuantiTect® SYBRGreen PCR Kit (Qiagen, USA)were used to perform
reverse transcription and quantitative PCR (qPCR), respectively.
Thermocycling and SYBR Green detection were performed on a Cor-
bett Rotorgene 6000 (Qiagen, USA) with extension at 72 C and
denaturing at 95 C. Annealing temperatures were primer speciﬁc.
Data were analyzed using the DDCt method [26]. The following
primers were used: MMP7 (Forward
50eGAGTGAGCTACAGTGGGAACAe30 and Reverse 50eCTATGAC
GCGGGAGTTTAACATe30), ADAMTS4 (Forward 50eGCAACG
TCAAGGCTCCTCTTe30 and Reverse 50eCTCCACAAATCTACTCA
GTGAAGCAe30), TIMP2 (Forward 50eTGGACGTTGGAGGAAAGA
AGe30 and Reverse 50eGGGCACAATGAAGTCACAGAe30), and TIMP3
(Forward 50eCTGCTGACAGGTCGCGTCe30 and Reverse 50eCAAC
CCAGGTGATACCGATAGTe30) at an annealing temperature of 52 C,
GAPDH (Quiagen, USA) (Forward 50eTGGTATCGTGGAAGGAC
TCATGAe30 and Reverse 50eATGCCAGTGAGCTTCCCGTTCAGe30),
COL1A1 (Forward 50eCATTAGGGGTCACAATGGTCe30 and Reverse
50eTGGAGTTCCATTTTCACCAGe30), COL2A1 (Forward 50eCATCCCA
CCCTCTCACAGTTe30 and Reverse 50eGTCTCTGCCT
TGACCCAAAGe30), COL10A1 (Forward 50eAATGCCTGTGTCTGC
TTTTACe30 and Reverse 50eACAAGTAAAGATTCCAGTCCTe30), and
ACAN (Forward 50eCACTGTTACCGCCACTTCCCe30 and Reverse
50eGACATCGTTCCACTCGCCCTe30) at an annealing temperature of
60 C, Runx2 (Forward 50eCCGCCTCAGTGATTTAGGGCe30 and
Reverse 50eGGGTCTGTAATCTGACTCTGTCCe30) at an annealing
temperature of 61 C, and SOX9 (Forward 50eAACGCCGAG
CTCAGCAAGe30 and Reverse 50eACGAACGGCCGC
TTCTCe30) at an annealing temperature of 62 C.
Fig. 2. Mechanical properties of Scl2 hydrogels. (A) Time to gelation at a temperature of 37 C, angular frequency of 6.28 rad/s, and strain of 0.5%. (B) Storage modulus determined
from strain sweep up to 1% strain at a temperature of 37 C and an angular frequency of 6.28 rad/s. (C) Dynamic mechanical analysis (DMA) used to determine the elastic modulus of
compression of hydrogels compressed to 10% strain at 0.5% strain/min and 1 Hz. Values represent means ± SD (n ¼ 3).
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All cellerelated experiments were repeated three times with
hMSCs from different donors and with an intraeexperimentalFig. 3. GAG binding on Scl2 hydrogels. (AeB) Binding of ﬂuorescentlyelabeled (A) HA and
(CeD) Release of ﬂuorescentlyelabeled (C) HA and (D) heparin from Scl2 hydrogels over 1 w
HA was normalized to the highest level of ﬂuorescent intensity at each time point to pro
***p < 0.001 (n ¼ 3).sample size of 3. Data are presented as means ± standard deviation
(SD). Statistical signiﬁcancewas determined by performing analysis
of variance (ANOVA) with Bonferroni correction and with a sig-
niﬁcance accepted at pevalue < 0.05.(B) heparin to Scl2. Empty wells were used as negative control denoted ‘no material’.
eek. The ﬂuorescence was measured in arbitrary units and relative binding of heparin or
vide the fraction of heparin or HA released over time. Values represent means ± SD.
Fig. 4. Degradation proﬁle of acellular Scl2 hydrogels. Degradation of hydrogels incubated in chondrogenic medium supplemented with 30 ng/mL recombinant human (A) MMP7 or
(B) ADAMTS4 over time characterized as dry weight loss and expressed as a percentage of initial dry weight. Degradation of hydrogels crosselinked via (C) MMP7 or (D) ADAMTS4
degradable peptides and exposed to 30 ng/mL recombinant human MMP1, 2, 7, or 13 over time characterized as dry weight loss and expressed as a percentage of initial dry weight.
Trypsinedriven degradation is used as a positive control. Chondrogenic medium without exogenous enzymes is used as a negative control. Values represent means ± SD.
***p < 0.001 versus MMP7:ACAN(25:75)-HIHA-Scl2 (n ¼ 3).
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3.1. Characterization of Scl2 proteins and acellular hydrogels
3.1.1. Scl2 protein characterization
FTIR spectroscopy was used to conﬁrm the conjugation of
crosselinking peptides to Scl2 proteins (Fig. S3). It showed IR
transmittance peaks at 1630 cm1 (amide C]O) that were assigned
to the Scl2 protein in all samples and used for normalizing. The
peak at 1110 cm1 (ether CeOeC) assigned to the acrylate was
present in all samples except the HIHA-Scl2 control.3.1.2. Mechanical and morphological characterization of hydrogels
For all hydrogels, the ratio of the peptide crosselinkers wasmodiﬁed, however, the total degree of crosselinking was kept
constant to maintain comparable mechanical properties and
minimize any potential effects of matrix stiffness on cell behavior
[27,28]. Oscillatory shear rheology conﬁrmed hydrogel formation
and was used to measure the storage modulus (Fig. 2 and Fig. S4).
No statistical differences in time to gelation and storage moduli
were observed. The equilibrium storage moduli of all samples
remained at ~7 kPa in the linear elastic region up to 10% strain.
Conﬁrming these observations, the compression moduli of the
hydrogels determined using unconﬁned DMA were found to range
between ~4 and 5 kPa at 1 Hz, and there were no statistical dif-
ferences in compression moduli between samples. Unlike PEG, a
commonly used hydrogel platform in cartilage tissue engineering,
the Scl2 hydrogels exhibited viscoelastic behavior, which may be a
Fig. 5. Metabolic activity and DNA content of hMSCs cultured in Scl2 hydrogels. (A) hMSC metabolic activity in hydrogels over 6 weeks in culture. (B) DNA content of hMSCs per
construct in hydrogels cultured over 6 weeks in culture. All data normalized to day 0. Values represent means ± SD. *p < 0.05 versus MMP7:ACAN(25:75)-HIHA-Scl2 (n ¼ 3 for each
donor; 3 different bone marrowederived hMSC donors).
P.A. Parmar et al. / Biomaterials 99 (2016) 56e7164more suitable replacement for tissues such as cartilage that also
behave as viscoelastic materials [29]. The viscoelasticity is
demonstrated by the fact that all hydrogels displayed increased
compression moduli with increasing frequency from 0.1 Hz
(~3 kPa) to 10 Hz (~6 kPa). Moreover, hydrogels imaged using
MPeSHG showed no differences in morphology (Fig. S5). Together
these observations indicate that the different crosselinking for-
mulations did not affect the mechanical or structural properties of
the hydrogels, and therefore we could compare the effects of the
different degradable crosselinkers decoupled from the initial me-
chanical properties and hydrogel structure.
3.1.3. GAGebinding properties of modiﬁed Scl2 proteins
Scl2 proteins functionalized with HAebinding or Hebinding
peptide sequences displayed speciﬁc binding to HA or heparin
(Fig. 3AeB), respectively. While there was some nonespeciﬁc
binding of HA and heparin to the HI-Scl2 and HA-Scl2 samples, this
binding was not statistically signiﬁcant when compared to the
unmodiﬁed Scl2 proteins. Additionally, all hydrogel formulations
showed a similar release of HA and heparin over time (Fig. 3CeD),
likely due to the HAebinding and Hebinding peptides increasing
the overall charge of the hydrogels similarly leading to comparable
binding with HA and heparin, respectively. This indicated that the
different degradable peptides did not exhibit any speciﬁc interac-
tion with HA or heparin. While both HA and heparin exhibited
burst release characteristics over the ﬁrst 3 days, possibly due to the
hydrophilicity of the hydrogels, it is likely that binding and release
of the GAGs from the hydrogels would be markedly different in the
presence of cells or in the native environment and it would be a
dynamic process.
3.2. Degradation kinetics
Fig. 4 demonstrates the degradation proﬁle of acellular hydro-
gels in the presence of recombinant human MMP7 and ADAMTS4
compared to trypsin, MMP1, MMP2, and MMP13. Hydrogels
crosselinked with the MMP7ecleavable peptide degraded much
faster in the presence of MMP7 compared to ADAMTS4, MMP1,
MMP2, andMMP13, for which cases less degradationwas observed.However, ADAMTS4 degraded the MMP7ecleavable peptide to a
greater extent than MMP1, MMP2, and MMP13, which could be
expected because the MMP7ecleavable peptide sequence previ-
ously demonstrated some susceptibility to cleavage by aggreca-
nases [11,21,30e32]. This indicates that a complete breakdown of
the hydrogel containing the MMP7ecleavable peptide crosselinker
may still be possible in later stages of chondrogenesis. Hydrogels
crosselinked with the ACANecleavable peptide degraded signiﬁ-
cantly more in the presence of ADAMTS4 compared to MMP1,
MMP2, MMP7, and MMP13, in which cases minimal degradation
was observed. This highlights the higher speciﬁcity of the
ACANecleavable peptide to ADAMTS4 compared to the
MMP7ecleavable peptide, which is susceptible to degradation by
both MMP7 and to a lesser extent ADAMTS4. The higher speciﬁcity
of the ACANecleavable peptide compared to the MMP7ecleavable
peptide may be advantageous in vivo because it suggests that
ACANecleavable peptide would hold the hydrogel structure
together to support the hMSCs until mature chondrocytes are
formed. Some nonespeciﬁc degradation of all hydrogels by MMP1,
MMP2, and MMP13 was observed, likely because MMPs are known
to recognize and cleave a range of peptide sequences
[4,11,24,30,33]. The combination of the MMP7e and ACANecleav-
able peptide crosselinkers led to similar degradation rates among
all hydrogel samples in the presence of ADAMTS4 compared to
hydrogel samples in the presence of MMP7, again demonstrating
some ability of ADAMTS4 to also degrade the MMP7ecleavable
peptide.
3.3. hMSC behavior in bioactive Scl2 hydrogels
3.3.1. Cell adhesion and viability
The metabolic activity of encapsulated hMSCs and DNA content
were maintained at consistently high levels for all hydrogel for-
mulations that only differed in the type of peptide crosselinker
throughout the culture period (Fig. 5). The longeterm viability of
encapsulated hMSCs in all hydrogels was further conﬁrmed quali-
tatively via a LIVE/DEAD® assay at day 42 (Fig. S6AeF). The effec-
tiveness of the I-binding peptide sequence incorporated into the
Scl2 backbone, previously shown to bind to the a1b1 and a2b1
Fig. 6. hMSC gene expression in Scl2 hydrogels. (A) COL2A1, (B) ACAN, (C) SOX9, (D) COL1A1, and (E) COL10A1 gene expression of hMSCs encapsulated in hydrogels over 6 weeks in
culture, as analyzed using the DDCt method. Data presented as a fold difference relative to undifferentiated hMSCs (calibrator) prior to encapsulation and normalized to GAPDH
(housekeeping gene). (F) COL2A1/COL1A1 gene expression ratio. Values represent means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 (n ¼ 3 for each donor; 3 different bone mar-
rowederived hMSC donors).
Fig. 7. ECM accumulation and compressive modulus of hMSCeseeded Scl2 hydrogels. (A) Sulfated glycosaminoglycan (sGAG) content of tissue deposited by hMSCs in hydrogels
over 6 weeks in culture. (B) Hydroxyproline content of tissue deposited by hMSCs in hydrogels over 6 weeks in culture as an estimation of total collagen content. (C) Dynamic
mechanical analysis (DMA) used to determine the elastic modulus of compression of hMSCeseeded hydrogels compressed to 10% strain at 0.5% strain/min and 0.1e10 Hz after 6
weeks in culture. Values represent means ± SD. *p < 0.05, **p < 0.01, ##p < 0.01 versus MMP7:ACAN(25:75)-HIHA-Scl2, ***p < 0.001 (n ¼ 3 for each donor; 3 different bone
marrowederived hMSC donors). (D) Representative histological and immunohistochemical examination of hMSCeseeded hydrogels after 6 weeks in culture. Hydrogels are stained
with Haematoxylin and Eosin (H&E), Alcian Blue for sGAG, and by immunohistochemistry for collagen type I, collagen type II, and collagen type X, respectively, from top to bottom.
Scale bars are 50 mm.
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P.A. Parmar et al. / Biomaterials 99 (2016) 56e7168integrins [15], was also validated (Fig. S7). These results suggest
that the combination of the Hebinding, HAebinding, and
Iebinding motifs on the Scl2 protein is sufﬁcient to promote
longeterm cell viability most likely through direct cell binding and
ECM binding interactions. The presence of the Hebinding,
Iebinding, and HAebinding peptides have previously been shown
to aid in maintaining longeterm cell viability and in impacting
biological processes through their interaction with heparin and HA
[11,15]. It should be mentioned that the metabolic activity of hMSCs
in the MMP7-HIHA-Scl2 and MMP7:ACAN(75:25)-HIHA-Scl2
hydrogels was signiﬁcantly lower compared to the other hydrogel
formulations at day 42. This is likely because these hydrogels with
the greatest proportion of MMP7 peptide are likely to degrade
faster, possibly decreasing matrix accumulation.3.3.2. In vitro chondrogenesis of hMSCs in degradable Scl2
hydrogels
The effects of the MMP7e and ACANecleavable peptide cross-
elinkers used alone or in combination on the chondrogenic dif-
ferentiation of encapsulated hMSCs were compared to the
nonedegradable ScrMMP7 peptide crosselinker control
[11,21,22,30,34]. The gene expression of chondrogenic markers
(COL2A1, ACAN, and SOX9) (Fig. 6AeC) all suggested that the
MMP7:ACAN(50:50)-HIHA-Scl2 and MMP7:ACAN(25:75)-HIHA-
Scl2 hydrogels, which are the hydrogel formulations containing a
combination of the degradable peptides, promoted chondrogenesis
of hMSCs to the greatest extent from week 2 to week 6. This result
suggests a unique and powerful synergistic effect due speciﬁcally to
the concurrent presentation of two distinct degradable peptide
motifs. Furthermore, the gene expression levels of chondrogenic
markers in our Scl2 hydrogels, particularly in the hydrogels with
dual peptides, are improved compared to the differentiation of
hMSCs in a pellet culture system at 2 weeks (Fig. S8) and pellet
culture systems reported in the literature [35]. Similarly interesting,
hMSCs in the ACAN-HIHA-Scl2 hydrogels had signiﬁcantly higher
COL2A1, ACAN, and SOX9 gene expression from week 2 to week 6
compared to the MMP7-HIHA-Scl2 hydrogels. This suggests that
the ACANecleavable peptide, which has not yet been explored for
tissue engineering applications with hMSCs, may have promoted
chondrogenesis on its own. However, this effect could also be due
to the degradation rate of the hydrogel at a speciﬁc time point or by
diverting ADAMTS4 to degrade the hydrogel rather than the
deposited matrix, meriting further exploration of this peptide for
cartilage tissue engineering applications.
Another unexpected observation was that hMSCs in the
ScrMMP7-HIHA-Scl2 hydrogels had higher gene expression of
ACAN and SOX9 at all time points compared to those in the MMP7-
HIHA-Scl2 hydrogels that reﬂected statistical reality. This is likely
because the MMP7-HIHA-Scl2 hydrogels degraded at a faster rate
compared to the ScrMMP7-HIHA-Scl2 hydrogels that are engi-
neered to be nonedegradable, resulting in less matrix accumula-
tion and thereby lesser impact on cell behavior. This highlights the
complexity involved in tuning the biodegradability of biomaterials
for optimal tissue regeneration. In accordance with our previous
work, it is not surprising that all hydrogels exhibited enhanced
chondrogenic marker gene expression proﬁles compared to un-
differentiated hMSCs [11]. This is likely because the HAebinding
and Hebinding peptides mimic proteineGAG interactions in theFig. 8. hMSC gene expression and enzymatic activity in Scl2 hydrogels. (A) MMP7, (B) ADA
over 6 weeks in culture, as analyzed using the DDCt method. Data presented as a fold
normalized to GAPDH (housekeeping gene). Activity of (E) MMP7 and (F) ADAMTS4 in hy
ﬂuorescence signal output at day 0. Values represent means ± SD. *p < 0.05, #p < 0.05 vers
HIHA-Scl2, ***p < 0.001, ###p < 0.001 versus MMP7:ACAN(25:75)-HIHA-Scl2 (n ¼ 3 for eacnative environment [22], thus validating the use of the modiﬁed
Scl2 protein for cartilage tissue engineering purposes. Additionally,
heparin is present in native articular cartilage and it is known to
recruit endogenous growth factors such as TGFeb, BMPs, and bFGF,
and form stable complexes that protect against proteolytic degra-
dation [36,37]. This can result in enhanced biological activity and
delayed growth factor release, which is considered important
because growth factors known to facilitate chondrogenesis such as
TGFeb have a relatively short halfelife. Thus, prolonging their
stability and possibly enhancing their biological activity in long-
eterm culture could indirectly promote chondrogenesis. Previous
studies have shown the presence of the RGD peptide sequence to be
important during early stage hMSC chondrogenesis [4]. However,
its persistence in hydrogel systems has been shown to delay or
inhibit complete chondrogenesis. It is possible that the I-binding
peptide had a similar effect to the RGD peptide on hMSC chon-
drogenesis. In contrast to gene expression proﬁles of chondrogenic
markers, hMSC gene expression levels of osteogenic (Runx2) and
lipogenic (PPAR-g) markers were downeregulated at week 2 and
thus, further conﬁrming that the hMSCs had committed towards
the chondrogenic lineage in our hydrogels (Fig. S8). Quantiﬁcation
of immunohistochemical staining for chondrogenic, osteogenic,
and lipogenic markers as an indicator of hMSC population hetero-
geneity further demonstrated that by 2 weeks, at least 60% of
hMSCswere committed to chondrogenesis in all hydrogels (Fig. S8).
Gene expression levels of COL1A1 by hMSCs were signiﬁcantly
elevated for the nonedegradable control and the conditions with
the greatest fraction of the MMP7ecleavable peptide at week 6,
including ScrMMP7-HIHA-Scl2 and MMP7:ACAN(75:25)-HIHA-
Scl2 hydrogels (Fig. 6D). COL1A1 is the major component of ﬁbro-
cartilage, which is characteristic of inadequate articular cartilage
healing and provides inferior mechanical properties compared to
collagen type II [38,39]. In addition, the hMSC gene expression
levels of COL10A1 were signiﬁcantly higher in MMP7-HIHA-Scl2
hydrogels at week 6 (Fig. 6E). Elevated COL10A1 is characteristic of
chondrocyte hypertrophy [40]. Thus, increased COL1A1 and
COL10A1 gene expression in the MMP7 peptideerich hydrogels
indicated progress towards terminal differentiation of hMSCs and a
hypertrophic phenotype, which is a critical complication for the
regeneration of articular cartilage tissue and for the potential use of
hMSCs in the clinic [11,41,42]. As such, the inhibition of hypertro-
phic marker gene expression by the ACANecleavable peptide alone
and to a greater extent in combination with the MMP7ecleavable
peptide is highly promising, and consistent with previous work
demonstrating that collagen type I and collagen type X deposition
by chondrocytes were decreased in hydrogels with the ACANe-
cleavable peptide crosselinked compared to nonedegradable
hydrogels [21]. This result demonstrates that the previously
observed improvements in cartilaginous matrix quality by chon-
drocytes can be translated to hMSCs undergoing chondrogenic
differentiation. The COL2A1/COL1A1 gene expression ratio, a
measure of the differentiation index [43], remained signiﬁcantly
higher for the MMP7:ACAN(25:75)-HIHA-Scl2 hydrogels compared
to the other hydrogel formulations throughout the culture period
(Fig. 6F). This implies that this speciﬁc combination of enzymee-
cleavable peptides with a larger fraction of the ACANecleavable
peptide maintained chondrogenic marker gene expression to the
greatest extent over 6 weeks of culture.MTS4, (C) TIMP2, and (D) TIMP3 gene expression of hMSCs encapsulated in hydrogels
difference relative to undifferentiated hMSCs (calibrator) prior to encapsulation and
drogels over 6 weeks in culture. MMP7 and ADAMTS4 activities were normalized to
us MMP7:ACAN(25:75)-HIHA-Scl2, **p < 0.01, ##p < 0.01 versus MMP7:ACAN(25:75)-
h donor; 3 different bone marrowederived hMSC donors).
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assessed for sGAG and collagen accumulation to further examine
the extent of chondrogenic differentiation, where cartilageespe-
ciﬁc matrix is predominantly characterized by sGAG and collagen
deposition [44]. sGAG content normalized to DNA (Fig. 7A) was
signiﬁcantly greater for the MMP7:ACAN(25:75)-HIHA-Scl2
hydrogels compared to all other hydrogel formulations at week 6.
Additionally, the total collagen content normalized to DNA (Fig. 7B)
was signiﬁcantly higher for the combined peptide conditions,
MMP7:ACAN(50:50)-HIHA-Scl2 and MMP7:ACAN(25:75)-HIHA-
Scl2, compared to all other samples at week 6. These combined
peptide conditions with highest matrix accumulation further
translated into signiﬁcantly higher compression moduli (Fig. 7C
and Fig. S9), which was further supported by their minimal
construct weight loss over time (Fig. S10). Moreover, the
compression moduli of the celleseeded hydrogels increased
slightly compared to acellular hydrogels during in vitro culture,
which is an interesting result because it is generally more common
for degradable hydrogel systems to exhibit a loss in compression
moduli. The compression moduli of the hydrogels is also expected
to demonstrate greater improvements in an in vivo setting for
treating focal defects in articular cartilage, and thus potentially
facilitating implantation and the longeterm performance [45].
Histological examination of the hydrogels indicated a sparse
distribution of cells and extensive matrix accumulation at day 42
compared to day 0, day 14, and day 21 (Fig. 7D, Fig. S11eS13). More
dispersed sGAG accumulation (Alcian Blue staining) was observed
in the MMP7:ACAN(50:50)-HIHA-Scl2 and MMP7:ACAN(25:75)-
HIHA-Scl2 hydrogels compared to the MMP7-HIHA-Scl2 and
ScrMMP7-HIHA-Scl2 samples, which was supported by the higher
sGAG accumulation results. Immunohistochemical staining for
collagen type II was noticeably increased compared to collagen type
I and collagen type X deposition in all hydrogels, indicating a
general promotion of the cartilageespeciﬁc phenotype for all
hydrogels [41,44]. The immunohistochemical images indicated that
at 6 weeks, levels of new matrix deposition were still far from
sufﬁcient to create a functional cartilaginous construct, however,
the matrix produced in all degradable constructs was of enhanced
quality compared to the nonedegradable control, which qualita-
tively exhibited the least matrix deposition. It is also possible that
mechanical stimulation of the constructs may help to enhance
matrix production by better simulating the native environment.
3.3.3. Temporal expression and activity of proteases
As matrix remodeling is closely associated with chondrogenesis
[46], and the hydrogels were speciﬁcally designed to respond to the
temporal expression of matrix remodeling enzymes, it was
important to conﬁrm the gene expression and activity of the tar-
geted proteases over the 6 week study. Overall, the gene expression
and activity of MMP7were highest fromweek 1 toweek 3, followed
by elevated ADAMTS4 gene expression and activity fromweek 3 to
week 6 (Fig. 8), validating the different temporal expression proﬁles
of these enzymes during the process of chondrogenesis. This data
supports our hypothesis that both enzymes are expressed during
the process of chondrogenesis, where MMP7 is expressed initially
and ADAMTS4 is expressed later following commitment to the
chondrocyte lineage [19,24]. Because there was minimal overlap in
the timeecourse of enzyme activity, it can be assumed that early
degradation was targeted speciﬁcally to the MMP7ecleavable
peptide, and later stage degradation would be predominantly tar-
geted to the ACANecleavable peptide. It is very difﬁcult to
deecouple hydrogel degradation from matrix accumulation and
potential biological signaling effects in a reliable and robust
manner. However, the dry weight change of acellular and
celleladen hydrogel constructs, alongside the analysis of acellulardegradation characteristics and enzymatic gene expression and
activity levels, can help provide an insight into the combined effect.
During the early stages of culture, where MMP7 activity was
highest, the construct weight decrease (Fig. S10) was signiﬁcantly
more drastic for the MMP7-HIHA-Scl2 and MMP7:ACAN(75:25)-
HIHA-Scl2 hydrogels, indicating that degradation was mostly
mediated via endogenous MMP7 rather than ADAMTS4. Because
some ADAMTS4emediated degradation was observed for the
MMP7ecleavable peptide (Fig. 4B), we can also infer that latere-
stage ADAMTS4 activity could also continue degrading any
remaining MMP7 peptide, which would be desirable in leading to
complete scaffold degradation over time.
Lookingmore closely at the results, the gene expression levels of
MMP7 were signiﬁcantly elevated in hMSCs encapsulated within
the MMP7:ACAN(25:75)-HIHA-Scl2 hydrogels compared to the
MMP7-HIHA-Scl2 and ACAN-HIHA-Scl2 hydrogels from week 1 to
week 2 (Fig. 8A). Furthermore, the gene expression of ADAMTS4
was signiﬁcantly greater in the same combined peptide hydrogel
formulation at week 6 (Fig. 8B). Since this was the condition
exhibiting the most chondrogenesisespeciﬁc gene markers and
highest cartilaginous matrix production, this also suggested that
elevated enzymeemediated scaffold degradation may be beneﬁcial
to the process of chondrogenesis and stimulating for matrix pro-
duction. Additionally, high levels of ADAMTS4 gene expression are
not observed in undifferentiated hMSCs [24,31,47], and high levels
of MMP7 gene expression are not known to be found in chon-
drocytes [24,30]. Therefore, our results suggest a transition from an
undifferentiated hMSC tomature chondrocyte phenotype after 3e4
weeks of culture in the bioactive Scl2 hydrogels. The hMSC gene
expression of TIMP2, a known inhibitor of MMP7 [48], exhibited a
reverse trend to MMP7 gene expression in all hydrogels with the
lowest levels present at week 1 and week 2 (Fig. 8C). Similarly, the
hMSC gene expression of TIMP3, a known inhibitor of ADAMTS4
[31,32,47], was reverseecorrelated with the ADAMTS4 gene
expression in all hydrogels, with the lowest levels measured at
week 4 and week 6 (Fig. 8D). In addition, heparin is a highly
sulfated GAG that is thought to promote the autolytic molecular
activation of proMMP7 and activity of MMP7 [30] as well as the
activity of ADAMTS4 [49]. These results further reveal an important
switch in cellular regulation processes during the 6 week culture
period in our novel bioactive hydrogels.
The compression moduli of the MMP7:ACAN(25:75)-HIHA-Scl2
hydrogels increased signiﬁcantly compared to the acellular coun-
terpart after 6 weeks (P < 0.01). Our results showed that these
combined cleavable peptide hydrogels accumulated a signiﬁcantly
greater amount of sGAG and total collagen as well as exhibiting
minimal construct weight loss compared to the MMP7-HIHA-Scl2
and MMP7:ACAN(25:75)-HIHA-Scl2 hydrogels, which likely
contributed to the improved compression moduli of the hydrogels.
After week 4, the construct weight change for the
MMP7:ACAN(50:50)-HIHA-Scl2 and MMP7:ACAN(25:75)-HIHA-Scl2
hydrogels plateaued and increased for the latter compared to the
MMP7-HIHA-Scl2 and MMP7:ACAN(75:25)-HIHA-Scl2 hydrogels,
suggesting a balance between the degradation of the hydrogel and
the accumulation of ECM, which is supported by the increased sGAG
and collagen deposition. This type of balance between scaffold
degradation and matrix production was predicted by computational
modeling simulations as the most optimal pattern to improve
cartilage tissue engineering outcomes when implementing degrad-
able scaffolds, and also points towards a more localized as opposed
to bulk degradation mode [50]. The ability to achieve scaffold
degradationwhilemaintaining overall mechanical integrity has been
noted as a major advantage for enzymatically degradable systems as
opposed to more passive, bulk degrading systems [21,51,52]. More-
over, it may be possible to conduct studies in an attempt to
P.A. Parmar et al. / Biomaterials 99 (2016) 56e7170deecouple hydrogel degradation and matrix accumulation by
observing the temporal biodegradability of hydrogels through radi-
oelabeling of the peptide crosselinkers, and these types of experi-
ments could be considered for future studies to further assess the
implications of temporal biodegradability. Additionally, the MMP7-
HIHA-Scl2 and MMP7:ACAN(75:25)-HIHA-Scl2 hydrogels swelled
signiﬁcantly more compared to the MMP7:ACAN(50:50)-HIHA-Scl2
and MMP7:ACAN(25:75)-HIHA-Scl2 hydrogels after 6 weeks
(Fig. S14), agreeing with the lower compression moduli of the
hydrogels containing a higher fraction of the MMP7ecleavable
peptide crosselinker compared to the combined peptide cross-
elinker hydrogels. It is known that the swelling behavior of native
tissues is closely linked to their compression moduli [53]. Hydrogels
crosselinked via the combination of MMP7e and ACANecleavable
peptides have demonstrated cellemediated degradation that en-
courages chondrogenesis and differentiation to a greater degree than
either peptide used alone [4,11,24,54e56], and in the current work
have been shown to maintain construct mechanical integrity as well
as a balance between scaffold degradation and matrix accumulation.
The use of the MMP7e and ACANecleavable peptides as cross-
elinkers within a single hydrogel system is shown to facilitate
complex, temporal degradation patterns that match the chondro-
genesis of encapsulated hMSCs, enabling accumulation and evolu-
tion of cartilageespeciﬁc matrix. To the best of our knowledge, this
study represents the ﬁrst demonstration of a bimodal enzymatically
degradable hydrogel, where the hydrogel design was tailored to
different temporal expression patterns of enzymes produced during
the chondrogenesis of hMSCs. The positive synergistic effect from
combining two distinct degradable peptides within one hydrogel
system is highly promising, meriting further investigation into
multimodal degradation approaches.
The successful use of multiple enzymaticallyecleavable peptides
in combination to tune hydrogel degradability and with a variety of
bioactive moieties highlights the possibility to facilitate complex
biological processes and more closely mimic the dynamics and
complexity of native tissue repair, regeneration, and remodeling.
Taking advantage of the modularity of our system, it is possible to
introduce greater complexity and ﬁne tuning to speciﬁc cellular
processes through the incorporation of other enzymeesensitive and
bioactive peptide sequences via tethering or siteedirected muta-
genesis to the Scl2 backbone. These key features of our hydrogel
platform can be especially advantageous for future clinical trans-
lation as it enables the ability to recapitulate a high degree of bio-
logical complexity in a controlled system, which could enhance
biorecognition by native cells and matrix molecules. Our novel Scl2
system provides a useful platform that can be easily adapted for
other applications in regenerative medicine and tissue engineering.
4. Conclusions
In this work, we designed and manufactured novel colla-
genemimetic hydrogels that can be speciﬁcally modiﬁed and
tailored to recapitulate features of the complex and dynamic ECM
of articular cartilage. Wemodiﬁed the backbone of ‘blank slate’ Scl2
proteins with Hebinding, Iebinding, and HAebinding sequences
through siteedirected mutagenesis. The proteins were cross-
elinked into injectable hydrogels via a combination of MMP7 and
ADAMTS4ecleavable peptides at varying ratios for cellemediated
degradation tuned to the temporal expression of catabolic enzymes
during and following chondrogenic differentiation of encapsulated
hMSCs. The combination of the MMP7 and ADAMTS4edegradable
crosselinkers signiﬁcantly enhanced the chondrogenesis of hMSCs
compared to the use of either peptide crosselinker alone. Specif-
ically, the MMP7:ACAN(50:50)-HIHA-Scl2 and
MMP7:ACAN(25:75)-HIHA-Scl2 hydrogels signiﬁcantlyuperegulated chondrogenic marker gene expression by hMSCs
resulting in the highest sGAG and collagen accumulation and
maintenance of mechanical integrity over the culture period, which
overcomes major challenges inherent to degradable constructs for
tissue engineering cartilage. These results suggest a balance be-
tween the degradation of the hydrogels and the accumulation of
matrix by hMSCs, which is an important result that also signiﬁes
the necessity to design more complex degradable constructs that
are responsive to temporal changes in cellular metabolism. Our
highly versatile hydrogels demonstrate the potential to facilitate
speciﬁc biological processes tomimic the dynamics and complexity
of native tissues, which could ultimately be translated into a
minimally invasive clinical approach to deliver autologous hMSCs
for cartilage regeneration therapies.
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